Arab Press

بالشعب و للشعب
Thursday, Dec 04, 2025

Doctor launches the first online clinic dedicated to using common drugs for a different purpose: to slow aging

Doctor launches the first online clinic dedicated to using common drugs for a different purpose: to slow aging

Sajad Zalzala wants to enable off-label uses of common drugs, like Metformin, to slow aging.

He’s starting an online clinic to help people get prescriptions for drugs like Metformin, which is increasingly popular in the tech community.

Metformin is routinely prescribed to people with diabetes, but some are using it in the hopes of slowing the aging process.

One of the many wild medical pursuits in Silicon Valley is the effort to slow down the aging process. Sajad Zalzala is trying to make it a reality.

Zalzala, a 38-year-old family medicine doctor based in the Detroit area, has just opened an online clinic called Qalytude, dedicated to anti-aging. As a physician licensed to practice in all 50 states, Zalzala can treat patients anywhere in the country by phone or online, in addition to those who visit his physical clinic.

Initially, Zalzala will be targeting the small but growing segment of Americans who take medicines like Metformin, a type 2 diabetes drug, but for the unintended purpose of staving off aging. Researchers are now finding evidence of reduced cancer risk in the drug, and studies in mice have shown potential for an improved life span, but scientists warn that it might not produce the same result in humans.

“There’s this movement around Metformin that I could see having a snowball effect,” Zalzala told CNBC.

He’s jumping into a market for anti-aging services, products and technologies that’s expected to reach $271 billion by 2024, according to Market Research Engine. Venture capital funds are dabbling in the space as are billionaires like Jeff Bezos and biohackers, who experiment with drugs and supplements for health and longevity purposes.


Making it easier

Zalzala said that only a few clinicians are trained in this field, and they’re highly costly to see and often backed up with patients. Many primary care physicians won’t prescribe Metformin to people who don’t have diabetes until they better understand whether it’s safe.

Zalzala’s goal is to make it easier for people interested in drugs like Metformin to talk to a physician. He plans to hire a team of doctors to conduct research into Metformin and other drugs — both their safety and efficacy — and prescribe them virtually to patients while monitoring them for side effects.

Having previously worked for a handful of virtual medical companies, including Hims and Pill Club, Zalzala is familiar with the model. Hims and Roman are among companies that have sprung up in recent years to help people get medications for erectile dysfunction and hair loss, the types of things that patients are often embarrassed to discuss with a family doctor. Other companies are prescribing medication virtually for birth control, sexual health and prevention, anxiety and attention deficit hyperactivity disorder.

Some of these companies require that patients talk to their doctor via video, while others request only that the user fill out a survey. The laws that govern how engaged a physician must be in the process vary by state.

For an area like anti-aging, a medical expert needs to be highly involved in the process.

These drugs “always must be prescribed by a doctor,” said Lisa Suennen, managing director of digital and technology at the law firm Manatt, Phelps and Phillips. “Any drug can be dangerous if it is mixed with something contraindicated,” and it’s especially important to be cautious when they’re being used “for claims that aren’t fully vetted.”

The side effects for Metformin include diarrhea, low blood sugar and abdominal pain, as well as a condition called lactic acidosis that involves excessive acid building up in the body. It also still isn’t well understood whether the drug will provide benefits to healthy people, particularly those who exercise regularly.

Another medicine Zalzala is exploring is rapamycin, which has an immunosuppressant function and is useful in helping patients avoid rejected transplanted kidneys. He’s also looking into so-called NAD booster patches. Both interventions are starting to get tested in the Silicon Valley tech community for their anti-aging effects, even though there are health risks.

Zalzala said he intends to be especially conservative with these untested therapies, but he didn’t rule out the possibility of prescribing them. He said that he will recommend lifestyle and dietary changes and not just pills.

“Most of us don’t have the perfect lifestyle,” he said. “So I’m hoping to add an extra layer of protection.”

Newsletter

Related Articles

Arab Press
0:00
0:00
Close
As Trump Deepens Ties with Saudi Arabia, Push for Israel Normalization Takes a Back Seat
Thai Food Village Debuts at Saudi Feast Food Festival 2025 Under Thai Commerce Minister Suphajee’s Lead
Saudi Arabia Sharpens Its Strategic Vision as Economic Transformation Enters New Phase
Saudi Arabia Projects $44 Billion Budget Shortfall in 2026 as Economy Rebalances
OPEC+ Unveils New Capacity-Based System to Anchor Future Oil Output Levels
Hong Kong Residents Mourn Victims as 1,500 People Relocated After Devastating Tower Fire
Saudi Arabia’s SAMAI Initiative Surpasses One-Million-Citizen Milestone in National AI Upskilling Drive
Saudi Arabia’s Specialty Coffee Market Set to Surge as Demand Soars and New Exhibition Drops in December
Saudi Arabia Moves to Open Two New Alcohol Stores for Foreigners Under Vision 2030 Reform
Saudi Arabia’s AI Ambitions Gain Momentum — but Water, Talent and Infrastructure Pose Major Hurdles
Tensions Surface in Trump-MBS Talks as Saudi Pushes Back on Israel Normalisation
Saudi Arabia Signals Major Maritime Crack-Down on Houthi Routes in Red Sea
Italy and Saudi Arabia Seal Over 20 Strategic Deals at Business Forum in Riyadh
COP30 Ends Without Fossil Fuel Phase-Out as US, Saudi Arabia and Russia Align in Obstruction Role
Saudi-Portuguese Economic Horizons Expand Through Strategic Business Council
DHL Commits $150 Million for Landmark Logistics Hub in Saudi Arabia
Saudi Aramco Weighs Disposals Amid $10 Billion-Plus Asset Sales Discussion
Trump Hosts Saudi Crown Prince for Major Defence and Investment Agreements
Families Accuse OpenAI of Enabling ‘AI-Driven Delusions’ After Multiple Suicides
Riyadh Metro Records Over One Hundred Million Journeys as Saudi Capital Accelerates Transit Era
Trump’s Grand Saudi Welcome Highlights U.S.–Riyadh Pivot as Israel Watches Warily
U.S. Set to Sell F-35 Jets to Saudi Arabia in Major Strategic Shift
Saudi Arabia Doubles Down on U.S. Partnership in Strategic Move
Saudi Arabia Charts Tech and Nuclear Leap Under Crown Prince’s U.S. Visit
Trump Elevates Saudi Arabia to Major Non-NATO Ally Amid Defense Deal
Trump Elevates Saudi Arabia to Major Non-NATO Ally as MBS Visit Yields Deepened Ties
Iran Appeals to Saudi Arabia to Mediate Restart of U.S. Nuclear Talks
Musk, Barra and Ford Join Trump in Lavish White House Dinner for Saudi Crown Prince
Lawmaker Seeks Declassification of ‘Shocking’ 2019 Call Between Trump and Saudi Crown Prince
US and Saudi Arabia Forge Strategic Defence Pact Featuring F-35 Sale and $1 Trillion Investment Pledge
Saudi Sovereign Wealth Fund Emerges as Key Contender in Warner Bros. Discovery Sale
Trump Secures Sweeping U.S.–Saudi Agreements on Jets, Technology and Massive Investment
Detroit CEOs Join White House Dinner as U.S.–Saudi Auto Deal Accelerates
Netanyahu Secures U.S. Assurance That Israel’s Qualitative Military Edge Will Remain Despite Saudi F-35 Deal
Ronaldo Joins Trump and Saudi Crown Prince’s Gala Amid U.S.–Gulf Tech and Investment Surge
U.S.–Saudi Investment Forum Sees U.S. Corporate Titans and Saudi Royalty Forge Billion-Dollar Ties
Elon Musk’s xAI to Deploy 500-Megawatt Saudi Data Centre with State-backed Partner HUMAIN
U.S. Clears Export of Advanced AI Chips to Saudi Arabia and UAE Amid Strategic Tech Partnership
xAI Selects Saudi Data-Centre as First Customer of Nvidia-Backed Humain Project
President Trump Hosts Saudi Crown Prince Mohammed bin Salman in Washington Amid Strategic Deal Talks
Saudi Crown Prince to Press Trump for Direct U.S. Role in Ending Sudan War
Trump Hosts Saudi Crown Prince: Five Key Takeaways from the White House Meeting
Trump Firmly Defends Saudi Crown Prince Over Khashoggi Murder Amid Washington Visit
Trump Backs Saudi Crown Prince Over Khashoggi Killing Amid White House Visit
Trump Publicly Defends Saudi Crown Prince Over Khashoggi Killing During Washington Visit
President Donald Trump Hosts Saudi Crown Prince Mohammed bin Salman at White House to Seal Major Defence and Investment Deals
Saudi Arabia’s Solar Surge Signals Unlikely Shift in Global Oil Powerhouse
Saudi Crown Prince Receives Letter from Iranian President Ahead of U.S. Visit
Saudi Arabia’s Crown Prince Begins Washington Visit to Cement Long-Term U.S. Alliance
Saudi Crown Prince Meets Trump in Washington to Deepen Defence, AI and Nuclear Ties
×